Retavase Powder For Solution For Injection 10.4U Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Retavase: Powder for solution for injection (10.4U)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

RETEPLASE (RE te plays) is used to dissolve blood clots that form in certain blood vessels. This medicine is used when a blood clot in a heart artery causes a heart attack.

In-Depth Information
Select a Medication

Retavase Kit Powder for Injection

NDC: 672860040
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Acute Myocardial Infarction, Coronary Artery Thrombosis

Sometimes used for but not FDA approved for the following conditions:
Occluded Arteriovenous (AV) Cannula, Occluded IV Catheter, Deep Venous Thrombosis (DVT), Arterial Thromboembolism

Storage Information
Protect from light
Store between 36 to 77 degrees F
Retavase Kit Powder for Injection

Reported Side Effects for Retavase Kit Powder for Injection

Bleeding In The Brain Incidence:
0.8%*
Severity: SEVERE
Onset: DELAYED
Anemia Incidence:
0.9-2.6%*
Severity: MODERATE
Onset: DELAYED
Intestinal Bleeding Incidence:
1.8-9.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding Incidence:
21.1%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Retavase

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5